Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Rectal Neoplasms 3 Breast Neoplasms 3 Esophageal Squamous Cell Carcinoma 2 Colonic Neoplasms 2 Carcinoma, Hepatocellular 2 Recurrence 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Oesophagogastric Cancer 1 Neoplasms 1 Inflammatory Breast Neoplasms 1 Fallopian Tube Neoplasms 1 Colorectal Neoplasms 1 Cholangiocarcinoma 1 Carcinoma, Ovarian Epithelial 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

Neoadjuvant Therapy 1 Lapatinib 1 Epirubicin 1 Cisplatin 1 Chemotherapy, Adjuvant 1 Capecitabine 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Oesophagogastric Cancer × Neoadjuvant Therapy × Clear all

NCT00450203 2016-12-01

ST03

Medical Research Council

Phase 2/3 Unknown

Gastrointestinal

Oesophagogastric Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡